---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-044547"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:22:20.706703+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardelyx Q3 revenue $98.2M; IBSRELA $40.6M, XPHOZAH $51.5M; net loss $0.8M

## Summary
- IBSRELA Q3 net sales $40.6M (+15% QoQ); full-year guidance set at $145-150M.
- XPHOZAH Q3 net sales $51.5M (+39% QoQ); strong launch continues.
- Total revenue $98.2M (up 74% YoY); net loss $0.8M vs net income $6.6M in Q3 2023.
- Cash $190.4M at Sep 30; drew $49.7M from SLR loan (SOFR+4.02%) in October.
- Appointed Eric Foster as CCO in August; CMS Part D change for XPHOZAH cited as 2025 headwind.

## SEC filing metadata
- accession: 0001628280-24-044547
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000162828024044547/0001628280-24-044547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000162828024044547/ardx-20241031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-044547
- JSON: https://secwatch.observer/filing/0001628280-24-044547.json
- Plain text: https://secwatch.observer/filing/0001628280-24-044547.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.